The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pediatric Medicines-Global Market Insights and Sales Trends 2024
Synopsis
The pediatric drug market plays a pivotal role in the pharmaceutical industry.
The global Pediatric Medicines market size is expected to reach US$ 136060 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Pediatric Medicines in various end use industries. The expanding demands from the Hospital, Clinic and Family,, are propelling Pediatric Medicines market. Enteral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Parenteral segment is estimated at % CAGR for the next seven-year period.
The pediatric medicines market identifies the formulatory advancement as one of the primary factors for this market’s growth.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pediatric Medicines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pediatric Medicines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pediatric Medicines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pediatric Medicines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pediatric Medicines covered in this report include GSK, Novartis, Pfizer, Sanofi, Abbott, Bristol-Myers Squibb, Cipla, Eisai Pharmaceuticals and Eli Lilly, etc.
The global Pediatric Medicines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Novartis
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai Pharmaceuticals
Eli Lilly
F. Hoffman-La Roche
Glenmark
Helsinn Healthcare
Heron Therapeutics
Ipca Laboratories
Global Pediatric Medicines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pediatric Medicines market, Segment by Type:
Enteral
Parenteral
Topical
Global Pediatric Medicines market, by Application
Hospital
Clinic
Family
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pediatric Medicines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pediatric Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The pediatric drug market plays a pivotal role in the pharmaceutical industry.
The global Pediatric Medicines market size is expected to reach US$ 136060 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Pediatric Medicines in various end use industries. The expanding demands from the Hospital, Clinic and Family,, are propelling Pediatric Medicines market. Enteral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Parenteral segment is estimated at % CAGR for the next seven-year period.
The pediatric medicines market identifies the formulatory advancement as one of the primary factors for this market’s growth.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pediatric Medicines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pediatric Medicines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pediatric Medicines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pediatric Medicines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pediatric Medicines covered in this report include GSK, Novartis, Pfizer, Sanofi, Abbott, Bristol-Myers Squibb, Cipla, Eisai Pharmaceuticals and Eli Lilly, etc.
The global Pediatric Medicines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Novartis
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai Pharmaceuticals
Eli Lilly
F. Hoffman-La Roche
Glenmark
Helsinn Healthcare
Heron Therapeutics
Ipca Laboratories
Global Pediatric Medicines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pediatric Medicines market, Segment by Type:
Enteral
Parenteral
Topical
Global Pediatric Medicines market, by Application
Hospital
Clinic
Family
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pediatric Medicines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pediatric Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Pediatric Medicines Market Overview
1.1 Pediatric Medicines Product Overview
1.2 Pediatric Medicines Market Segment by Type
1.2.1 Enteral
1.2.2 Parenteral
1.2.3 Topical
1.3 Global Pediatric Medicines Market Size by Type
1.3.1 Global Pediatric Medicines Market Size Overview by Type (2018-2029)
1.3.2 Global Pediatric Medicines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Pediatric Medicines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pediatric Medicines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Pediatric Medicines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Pediatric Medicines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Pediatric Medicines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Pediatric Medicines Sales Breakdown by Type (2018-2023)
2 Global Pediatric Medicines Market Competition by Company
2.1 Global Top Players by Pediatric Medicines Sales (2018-2023)
2.2 Global Top Players by Pediatric Medicines Revenue (2018-2023)
2.3 Global Top Players by Pediatric Medicines Price (2018-2023)
2.4 Global Top Manufacturers Pediatric Medicines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pediatric Medicines Market Competitive Situation and Trends
2.5.1 Pediatric Medicines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Pediatric Medicines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Medicines as of 2022)
2.7 Date of Key Manufacturers Enter into Pediatric Medicines Market
2.8 Key Manufacturers Pediatric Medicines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pediatric Medicines Status and Outlook by Region
3.1 Global Pediatric Medicines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Pediatric Medicines Historic Market Size by Region
3.2.1 Global Pediatric Medicines Sales in Volume by Region (2018-2023)
3.2.2 Global Pediatric Medicines Sales in Value by Region (2018-2023)
3.2.3 Global Pediatric Medicines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Pediatric Medicines Forecasted Market Size by Region
3.3.1 Global Pediatric Medicines Sales in Volume by Region (2024-2029)
3.3.2 Global Pediatric Medicines Sales in Value by Region (2024-2029)
3.3.3 Global Pediatric Medicines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Pediatric Medicines by Application
4.1 Pediatric Medicines Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Family
4.2 Global Pediatric Medicines Market Size by Application
4.2.1 Global Pediatric Medicines Market Size Overview by Application (2018-2029)
4.2.2 Global Pediatric Medicines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Pediatric Medicines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pediatric Medicines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Pediatric Medicines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Pediatric Medicines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Pediatric Medicines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Pediatric Medicines Sales Breakdown by Application (2018-2023)
5 North America Pediatric Medicines by Country
5.1 North America Pediatric Medicines Historic Market Size by Country
5.1.1 North America Pediatric Medicines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Pediatric Medicines Sales in Volume by Country (2018-2023)
5.1.3 North America Pediatric Medicines Sales in Value by Country (2018-2023)
5.2 North America Pediatric Medicines Forecasted Market Size by Country
5.2.1 North America Pediatric Medicines Sales in Volume by Country (2024-2029)
5.2.2 North America Pediatric Medicines Sales in Value by Country (2024-2029)
6 Europe Pediatric Medicines by Country
6.1 Europe Pediatric Medicines Historic Market Size by Country
6.1.1 Europe Pediatric Medicines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Pediatric Medicines Sales in Volume by Country (2018-2023)
6.1.3 Europe Pediatric Medicines Sales in Value by Country (2018-2023)
6.2 Europe Pediatric Medicines Forecasted Market Size by Country
6.2.1 Europe Pediatric Medicines Sales in Volume by Country (2024-2029)
6.2.2 Europe Pediatric Medicines Sales in Value by Country (2024-2029)
7 Asia-Pacific Pediatric Medicines by Region
7.1 Asia-Pacific Pediatric Medicines Historic Market Size by Region
7.1.1 Asia-Pacific Pediatric Medicines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Pediatric Medicines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Pediatric Medicines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Pediatric Medicines Forecasted Market Size by Region
7.2.1 Asia-Pacific Pediatric Medicines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Pediatric Medicines Sales in Value by Region (2024-2029)
8 Latin America Pediatric Medicines by Country
8.1 Latin America Pediatric Medicines Historic Market Size by Country
8.1.1 Latin America Pediatric Medicines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Pediatric Medicines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Pediatric Medicines Sales in Value by Country (2018-2023)
8.2 Latin America Pediatric Medicines Forecasted Market Size by Country
8.2.1 Latin America Pediatric Medicines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Pediatric Medicines Sales in Value by Country (2024-2029)
9 Middle East and Africa Pediatric Medicines by Country
9.1 Middle East and Africa Pediatric Medicines Historic Market Size by Country
9.1.1 Middle East and Africa Pediatric Medicines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Pediatric Medicines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Pediatric Medicines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Pediatric Medicines Forecasted Market Size by Country
9.2.1 Middle East and Africa Pediatric Medicines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Pediatric Medicines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Pediatric Medicines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GSK Pediatric Medicines Products Offered
10.1.5 GSK Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis Pediatric Medicines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novartis Pediatric Medicines Products Offered
10.2.5 Novartis Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Pediatric Medicines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Pediatric Medicines Products Offered
10.3.5 Pfizer Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Pediatric Medicines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Pediatric Medicines Products Offered
10.4.5 Sanofi Recent Development
10.5 Abbott
10.5.1 Abbott Company Information
10.5.2 Abbott Introduction and Business Overview
10.5.3 Abbott Pediatric Medicines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Abbott Pediatric Medicines Products Offered
10.5.5 Abbott Recent Development
10.6 Bristol-Myers Squibb
10.6.1 Bristol-Myers Squibb Company Information
10.6.2 Bristol-Myers Squibb Introduction and Business Overview
10.6.3 Bristol-Myers Squibb Pediatric Medicines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bristol-Myers Squibb Pediatric Medicines Products Offered
10.6.5 Bristol-Myers Squibb Recent Development
10.7 Cipla
10.7.1 Cipla Company Information
10.7.2 Cipla Introduction and Business Overview
10.7.3 Cipla Pediatric Medicines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Cipla Pediatric Medicines Products Offered
10.7.5 Cipla Recent Development
10.8 Eisai Pharmaceuticals
10.8.1 Eisai Pharmaceuticals Company Information
10.8.2 Eisai Pharmaceuticals Introduction and Business Overview
10.8.3 Eisai Pharmaceuticals Pediatric Medicines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Eisai Pharmaceuticals Pediatric Medicines Products Offered
10.8.5 Eisai Pharmaceuticals Recent Development
10.9 Eli Lilly
10.9.1 Eli Lilly Company Information
10.9.2 Eli Lilly Introduction and Business Overview
10.9.3 Eli Lilly Pediatric Medicines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Eli Lilly Pediatric Medicines Products Offered
10.9.5 Eli Lilly Recent Development
10.10 F. Hoffman-La Roche
10.10.1 F. Hoffman-La Roche Company Information
10.10.2 F. Hoffman-La Roche Introduction and Business Overview
10.10.3 F. Hoffman-La Roche Pediatric Medicines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 F. Hoffman-La Roche Pediatric Medicines Products Offered
10.10.5 F. Hoffman-La Roche Recent Development
10.11 Glenmark
10.11.1 Glenmark Company Information
10.11.2 Glenmark Introduction and Business Overview
10.11.3 Glenmark Pediatric Medicines Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Glenmark Pediatric Medicines Products Offered
10.11.5 Glenmark Recent Development
10.12 Helsinn Healthcare
10.12.1 Helsinn Healthcare Company Information
10.12.2 Helsinn Healthcare Introduction and Business Overview
10.12.3 Helsinn Healthcare Pediatric Medicines Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Helsinn Healthcare Pediatric Medicines Products Offered
10.12.5 Helsinn Healthcare Recent Development
10.13 Heron Therapeutics
10.13.1 Heron Therapeutics Company Information
10.13.2 Heron Therapeutics Introduction and Business Overview
10.13.3 Heron Therapeutics Pediatric Medicines Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Heron Therapeutics Pediatric Medicines Products Offered
10.13.5 Heron Therapeutics Recent Development
10.14 Ipca Laboratories
10.14.1 Ipca Laboratories Company Information
10.14.2 Ipca Laboratories Introduction and Business Overview
10.14.3 Ipca Laboratories Pediatric Medicines Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Ipca Laboratories Pediatric Medicines Products Offered
10.14.5 Ipca Laboratories Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pediatric Medicines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pediatric Medicines Industrial Chain Analysis
11.4 Pediatric Medicines Market Dynamics
11.4.1 Pediatric Medicines Industry Trends
11.4.2 Pediatric Medicines Market Drivers
11.4.3 Pediatric Medicines Market Challenges
11.4.4 Pediatric Medicines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pediatric Medicines Distributors
12.3 Pediatric Medicines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
